Viewing Study NCT06271369


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2025-12-25 @ 8:16 PM
Study NCT ID: NCT06271369
Status: COMPLETED
Last Update Posted: 2024-02-21
First Post: 2024-02-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Real-World HRU and Costs in DLBCL Pts With Tisa-cel and Axi-cel, a Medicare Study.
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module